Pancreatic Cancer Research

ResearcherCarol Davila University of Medicine and PharmacyActive in the last 2 years

Cristian Gheorghe

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-7969-628X; OpenAlex author ID A5055978007, A5157824913. Sources: OpenAlex.

Their work

Papers
13 (first author 0, last author 7)
Trials
0
Grants
0
Labs led
1
Collaborators
15
Papers, trials and grants by year

2018: 2 papers · 2019: 1 paper · 2020: none · 2021: 2 papers · 2022: 2 papers · 2023: 2 papers · 2024: 2 papers · 2025: 1 paper · 2026: 1 paper

Papers 13

  1. Unexpected Long-Term Survival in Resected Pancreatic Ductal Adenocarcinoma Harboring KRAS G12R with an Ultra-Low-VAF SMAD4 Mutation: A Case Report and Mini-Rev… Last author DOI 10.3390/reports9030285↗
  2. Endoscopic Ultrasound-Guided Radiofrequency Ablation for Pancreatic Adenocarcinoma: A Scoping Review with Meta-Analysis. Co-author DOI 10.3390/diagnostics15040437↗
  3. Prognostic Value of Circulating Cell-Free DNA Concentration and Neutrophil-to-Lymphocyte Ratio in Patients with Pancreatic Ductal Adenocarcinoma: A Prospective… Last author DOI 10.3390/ijms25052854↗
  4. Pancreatic Cancer: A Review of Risk Factors. Last author DOI 10.3390/life14080980↗
  5. Real-Life Results of Palliative Chemotherapy in Metastatic Pancreatic Ductal Adenocarcinoma. Last author DOI 10.3390/cancers15133500↗
  6. Endoscopic ultrasound-guided fine-needle aspiration pancreatic adenocarcinoma samples yield adequate DNA for next-generation sequencing: A cohort analysis. Last author DOI 10.3748/wjg.v29.i18.2864↗
  7. Prognostic role of cell-free DNA biomarkers in pancreatic adenocarcinoma: A systematic review and meta-analysis. Co-author DOI 10.1016/j.critrevonc.2021.103548↗
  8. Exosomes as prognostic biomarkers in pancreatic ductal adenocarcinoma-a systematic review and meta-analysis. Co-author DOI 10.1016/j.trsl.2022.01.001↗
  9. Genome-wide scan of long noncoding RNA single nucleotide polymorphisms and pancreatic cancer susceptibility. Co-author DOI 10.1002/ijc.33475↗
  10. Associations between pancreatic expression quantitative traits and risk of pancreatic ductal adenocarcinoma. Co-author DOI 10.1093/carcin/bgab057↗
  11. Germline BRCA2 K3326X and CHEK2 I157T mutations increase risk for sporadic pancreatic ductal adenocarcinoma. Co-author DOI 10.1002/ijc.32127↗
  12. Early detection of advanced pancreatic cancer after DAA-induced virological cure in a liver transplant recipient with hepatitis C recurrence Last author DOI 10.15403/jgld.2014.1121.271.daa↗
  13. Very Early Onset Pancreatic Adenocarcinoma - Clinical Presentation, Risk Factors and Therapeutic Options. Last author DOI 10.21614/chirurgia.113.3.405↗

Closest collaborators

The 15 strongest of 15 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Bianca Varzaru · 4 shared papers, 2023–2026 · strength 0.87
  2. Ștefania Bunduc · 5 shared papers, 2018–2024 · strength 0.74
  3. Simona Dima · 3 shared papers, 2023–2026 · strength 0.66
  4. Irinel Popescu · 3 shared papers, 2018–2024 · strength 0.44
  5. Ioana Gabriela Lupescu · 2 shared papers, 2018–2026 · strength 0.41
  6. Raluca Roxana Grigorescu · 1 shared paper, 2024 · strength 0.36
  7. Alexandra Mikó · 2 shared papers, 2022 · strength 0.30
  8. Daniela Tabacelia · 1 shared paper, 2025 · strength 0.27
  9. Cristian George Ţieranu · 1 shared paper, 2025 · strength 0.27
  10. Mariana Jinga · 1 shared paper, 2025 · strength 0.27
  11. Daniel Vasile Balaban · 1 shared paper, 2025 · strength 0.27
  12. Stephen P. Pereira · 1 shared paper, 2025 · strength 0.27
  13. Adrian Săftoiu · 1 shared paper, 2025 · strength 0.27
  14. Péter Jenő Hegyi · 1 shared paper, 2022 · strength 0.15
  15. Carmen Cristina Ester · 1 shared paper, 2018 · strength 0.10

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.